Textron Inc. · TXT · FY2024 Q3 · Calendar Q4 2024
Textron cuts guidance after aviation strike disrupts Q3
The supplied analysis supports a mixed recovery thesis: Textron has meaningful aviation and defense backlog, aftermarket growth and FLRAA program momentum, but the latest quarter shows that earnings growth depends on restoring production, managing costs and converting program milestones into execution.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about TXT FY2024 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter's maintained guidance and confident tone, the latest analysis shows a cautious tone and lowered guidance. The central change was a five-week aviation strike that caused a $0.5 billion revenue impact, reduced earnings and created inventory and recovery risks; against that, aviation backlog, new orders and FLRAA Milestone B strengthened the forward program base.
Guidance delta
Lowered: management revised full-year EPS guidance to $5.40-$5.60 after the aviation strike disrupted production.
Key takeaways
- Revenue modestly increased, but adjusted earnings fell to $1.40 per share as the five-week aviation strike disrupted production.
- Aviation backlog was $7.6 billion, with more than $1 billion of new orders supporting the recovery case.
- FLRAA Milestone B approval added $2.3 billion to Bell's backlog, while industrial softness and strike-related inventory remain risks.
Management priorities
- Ramp Aviation production after the strike and restore the workforce by early Q4
- Advance FLRAA toward critical design review and first flight in 2026
- Execute Nuuva 300, Nexus, robotic-vehicle and product-refresh programs while improving supply-chain efficiency
Follow TXT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 9, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 7, 2026 |
| UBS | Neutral | Neutral | Maintain | May 4, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 4, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 7, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Feb 19, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Oct 29, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2025 |
| Susquehanna | Positive | Positive | Maintain | Jul 25, 2025 |
| Goldman Sachs | Neutral | Buy | Downgrade | Jul 1, 2025 |
| B of A Securities | Neutral | Buy | Downgrade | Jan 24, 2025 |
| Baird | Outperform | Outperform | Maintain | Jan 23, 2025 |
| Veritas Research | Hold | Buy | Downgrade | May 24, 2023 |
| Alembic Global | Neutral | Overweight | Downgrade | May 1, 2023 |
| Wolfe Research | Perform | Peer Perform | Maintain | Apr 6, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 14, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Aug 31, 2021 |
| Bank of America | Neutral | Buy | Downgrade | Oct 22, 2019 |
| Vertical Research | Hold | Buy | Downgrade | Sep 27, 2019 |
| Wells Fargo | Outperform | Outperform | Maintain | Oct 19, 2018 |
| Drexel Hamilton | Buy | Hold | Upgrade | Sep 11, 2017 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Apr 13, 2017 |
| Deutsche Bank | Hold | Hold | Maintain | Dec 5, 2016 |
| Nomura | Buy | Neutral | Upgrade | Mar 6, 2015 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Sep 26, 2014 |
| Stifel | Buy | Hold | Upgrade | Sep 26, 2014 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jan 7, 2013 |
| Early Bird Capital | Buy | Buy | Maintain | Jul 19, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $78.11. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $86 | $75.15 | +10.1% | Oct 16, 2026 |
| UBS | Gavin Parsons | $95 | $89.96 | +21.6% | Jul 29, 2026 |
| Morgan Stanley | Kristine Liwag | $98 | $89.96 | +25.5% | Jul 29, 2026 |
| Morgan Stanley | Kristine Liwag | $97 | $89.5 | +24.2% | Jul 15, 2026 |
| UBS | Analyst unavailable | $100 | $92.78 | +28.0% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $109 | $94.08 | +39.5% | May 4, 2026 |
| Bernstein | Douglas Harned | $108 | $100.25 | +38.3% | Feb 19, 2026 |
| Jefferies | Analyst unavailable | $110 | $88.06 | +40.8% | Feb 1, 2026 |
| Morgan Stanley | Kristine Liwag | $92 | $88.2 | +17.8% | Jan 29, 2026 |
| Susquehanna | Charles Minervino | $110 | $93.49 | +40.8% | Jan 15, 2026 |
| UBS | Analyst unavailable | $99 | $93.86 | +26.7% | Jan 15, 2026 |
| Jefferies | Analyst unavailable | $115 | $93.62 | +47.2% | Jan 15, 2026 |
| Bernstein | Analyst unavailable | $94 | $89.15 | +20.3% | Jan 6, 2026 |
| Bernstein | Douglas Harned | $90 | $80.48 | +15.2% | Oct 27, 2025 |
| UBS | Analyst unavailable | $89 | $79.88 | +13.9% | Oct 24, 2025 |
| Susquehanna | Charles Minervino | $90 | $75.6 | +15.2% | Jan 8, 2025 |
| Jefferies | Sheila Kahyaoglu | $100 | $81.77 | +28.0% | Oct 30, 2024 |
| Morgan Stanley | Kristine Liwag | $95 | $83.46 | +21.6% | Aug 8, 2024 |
| UBS | Gavin Parsons | $87 | $92.62 | +11.4% | Jul 19, 2024 |
| Goldman Sachs | Analyst unavailable | $93 | $70.17 | +19.1% | Dec 15, 2022 |
| Susquehanna | Analyst unavailable | $84 | $65.38 | +7.5% | Jul 29, 2022 |
| Barclays | Analyst unavailable | $85 | $70.02 | +8.8% | May 2, 2022 |
| Capital One Financial | Jonathan Raviv | $68 | $64.17 | -12.9% | Apr 30, 2021 |
Track every rating change on TXT the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTextron Inc. (TXT) is a diverse global enterprise with significant involvement in the aerospace, defense, industrial, and financial sectors. Its Textron Aviation division is responsible for the production, sale, and maintenance of a variety of aircraft, including corporate jets, turboprop and piston-engine planes, and military trainer and defense aircraft. This segment also delivers extensive maintenance, inspection, and repair services, alongside selling commercial aircraft components. The Bell segment stands as a primary provider of military and civilian helicopters, in addition to tiltrotor aircraft, supported by related spare parts and services. Textron Systems focuses on developing and supplying advanced unmanned aerial platforms, sophisticated electronic systems and solutions, specialized marine vessels, piston aircraft engines, realistic live military air-to-air and air-to-ship training systems, weaponry and associated components, and a range of armored and specialty vehicles.…
Historical context
All TXT earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| BAH Booz Allen Hamilton Holding Corporation | FY2027 Q2 · Calendar Q4 2026 | +18.9% | -0.3% | Booz Allen pairs modest revenue decline with stronger defense-tech focus |
| FIX Comfort Systems USA, Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.2% | -8.5% | Comfort Systems USA: Strong Growth, Record Backlog, Margin Watchpoints |
| BE Bloom Energy Corporation | FY2026 Q3 · Calendar Q4 2026 | +36.0% | -8.7% | Bloom Energy Raises Outlook as AI Power Demand Drives Expansion |
| SNA Snap-on Incorporated | FY2026 Q3 · Calendar Q4 2026 | -5.9% | -3.4% | Snap-on: C&I strength offsets organic sales pressure in Q3 |
| HON Honeywell International Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.6% | +1.7% | Honeywell Raises 2026 Outlook as Backlog and Forge Support Growth |
| LMT Lockheed Martin Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.0% | +7.0% | Lockheed Martin: backlog and guidance rise, with execution risks |
Latest beats and misses
Who reports nextBeat on EPS
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
Missed on EPS
- KOFFY2026 Q3 · October 26, 2026-9.0% EPS-1.9% move
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
Get the TXT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-27T08:10:43.298150+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T08:10:43.295395+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.